Thrombosis is the primary barrier to the long-term patency of vascular grafts. Strategies adapted for antithrombogenic applications mainly involve coating the surfaces with anticoagulants such as heparin or vasodilators and inhibitors of platelet activation such as nitric oxide, inhibitors of protein adsorption such as poly(ethylene glycol) (PEG) or zwitterionic polymers, and synthetic drugs.